For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/
Daiichi Sankyo Appoints New Group Corporate Officers
Tokyo, Japan (March 3, 2014) – Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2014.
1. DAIICHI SANKYO CO., LTD.
|
New Position
|
Name
|
Current Position
|
|
Representative Director,
President and CEO
|
Joji Nakayama
|
Representative Director,
President and CEO and
President of Japan Company
|
|
Member of the Board,
Executive Vice President, Head of Supply Chain Division and Legal Affairs & CSR Division and
General Affairs & Human Resources Division
|
Yuki Sato
|
Member of the Board, Senior Executive Officer,
Head of Supply Chain Division and
Legal Affairs & CSR Division
|
|
Member of the Board,
Executive Vice President, Head of Corporate Management Division
|
Manabu Sakai
|
Member of the Board, Senior Executive Officer, Head of Corporate Management Division
|
|
Member of the Board,
Senior Executive Officer, Head of Vaccine Business Intelligence Division
|
Takeshi Ogita
|
Member of the Board, Senior Executive Officer, Head of General Affairs & Human Resources Division and Vaccine Business Intelligence Division, Japan Company
|
|
Member of the Board,
Senior Executive Officer, Head of Corporate Strategy Division
|
Kazunori Hirokawa
|
Member of the Board, Senior Executive Officer, Head of Corporate Strategy Division and Business Intelligence Division, Japan Company
|
|
Executive Officer,
President of Japan Company and Head of Business Intelligence Division, Japan Company
|
Sunao Manabe
|
Corporate Officer, Vice President of Corporate Strategy Department, Corporate Strategy Division
|
|
Executive Officer,
Vice President of Corporate Strategy Department, Corporate Strategy Division
|
Toshiaki Sai
|
Corporate Officer, Vice President of Global Brand Strategy Department, Corporate Strategy Division
|
|
Executive Officer,
Head of Pharmaceutical Technology Division
|
Katsumi Fujimoto
|
Corporate Officer, Head of Pharmaceutical Technology Division
|
|
Executive Officer, Head of Quality and Safety Management Division
|
Toshiaki Tojo
|
Corporate Officer, Head of Quality and Safety Management Division
|
|
Corporate Officer,
Vice President of Secretariat Department,
General Affairs & Human Resources Division
|
Ryoji Nagasaka
|
Corporate Officer, Vice President of Kyushu Branch, Sales & Marketing Division, Japan Company
|
Corporate Officer,
Vice President of Intellectual Property
Department, Corporate Strategy Division
|
Kazuo Sato
|
Corporate Officer, Vice President of Business Development & Licensing Department, Corporate Strategy Division
|
|
New Position
|
Name
|
Current Position
|
|
Corporate Officer,
Vice President of External Affairs Department,
Business Intelligence Division, Japan Company
|
Kazuyuki Watanabe
|
Vice President of External Affairs Department,
Business Intelligence Division, Japan Company
|
|
Corporate Officer,
Vice President of Japan Development Oversight Function, R&D Division
|
Kohei Wada
|
Vice President of Global Project Management Department, R&D Division
|
|
Corporate Officer,
Head of Sales & Marketing Divsion and
Vice President of Marketing Department,
Japan Company
|
Satoru Kimura
|
Vice President of Kyoto Branch , Sales & Marketing Division, Japan Company
|
|
Corporate Officer,
Vice President of Research Oversight Function, R&D Division
|
Masahiko Ohtsuki
|
Vice President of Research Oversight Function, R&D Division
|
◇Takeshi Ogita (current Member of the Board, Senior Executive Officer) will be additionally appointed Representative Director and President of Kitasato Daiichi Sankyo Vaccine Co., Ltd. as of April 1st, 2014.
◇Ryoichi Kibushi (current Senior Executive Officer) will become Corporate Advisor as of April 1st, 2014.
◇Tomoo Yokoi (current Executive Officer) will become Corporate Advisor as of April 1st, 2014.
◇Katsuaki Miyoshi (current Corporate Officer) will be appointed Member of the Board and Executive Vice President of Daiichi Sankyo Business Associe Co., Ltd. as of April 1st, 2014.
◇Satoshi Kunitada (current Corporate Officer) will be appointed Member of the Board and Executive Vice President of Daiichi Sankyo RD Novare Co., Ltd. as of April 1st, 2014.
【Management structure as of April 1st, 2014】
|
Position
|
Name
|
Responsibilities
|
|
Representative Director,
Chairman
|
Takashi Shoda
|
|
|
Representative Director,
President and CEO
|
Joji Nakayama
|
|
|
Member of the Board,
Executive Vice President
|
Yuki Sato
|
Head of Supply Chain Division and
Legal Affairs & CSR Division and
General Affairs & Human Resources Division
|
|
Manabu Sakai
|
Head of Corporate Management Division
|
|
Member of the Board,
Senior Executive Officer
|
Takeshi Ogita
|
Head of Vaccine Business Intelligence Division
|
|
Kazunori Hirokawa
|
Head of Corporate Strategy Division
|
|
Member of the Board (Outside)
|
Hiroshi Hirabayashi
|
|
|
Kunio Ishihara
|
|
|
Ichiro Kanazawa
|
|
|
Seiji Sugiyama
|
|
|
Position
|
Name
|
Responsibilities
|
|
Member of the Audit and Supervisory Board
|
Kazuo Koike
|
|
|
Takashi Chiba
|
|
|
Member of the Audit and Supervisory Board (Outside)
|
Akio Yamada
|
|
|
Shigeaki Ishikawa
|
|
|
Senior Executive Officer
|
Glenn Gormley
|
Head of R&D Division
|
|
Executive Officer
|
Shuji Handa
|
President of ASCA Company
|
|
Sunao Manabe
|
President of Japan Company and
Head of Business Intelligence Division,
Japan Company
|
|
Toshiaki Sai
|
Vice President of Corporate Strategy Department, Corporate Strategy Division
|
|
Katsumi Fujimoto
|
Head of Pharmaceutical Technology Division
|
|
Toshiaki Tojo
|
Head of Quality and Safety Management Division
|
|
Corporate Officer
|
Noriaki Ishida
|
Vice President of Corporate Communications
Department, Corporate Management Division
|
|
Shinichi Terano
|
Vice President of Tokyo Branch,
Sales & Marketing Division, Japan Company
|
|
Ryoji Nagasaka
|
Vice President of Secretariat Department,
General Affairs & Human Resources Division
|
|
Junichi Koga
|
Vice President of Biologics Oversight Function, R&D Division
|
|
Koichi Akahane
|
Vice President of R&D Planning Department,
R&D Division
|
|
Kenji Inoue
|
Vice President of Osaka Branch,
Sales & Marketing Division, Japan Company
|
|
Kazuo Sato
|
Vice President of Intellectual Property Department, Corporate Strategy Division
|
|
Norimasa Kamura
|
Vice President of Human Resources Department,
General Affairs & Human Resources Division
|
|
Kazuyuki Watanabe
|
Vice President of External Affairs Department,
Business Intelligence Division, Japan Company
|
|
Kohei Wada
|
Vice President of Japan Development Oversight Function, R&D Division
|
|
Satoru Kimura
|
Head of Sales & Marketing Division and
Vice President of Marketing Department,
Japan Company
|
|
Masahiko Ohtsuki
|
Vice President of Research Oversight Function,
R&D Division
|
2．DAIICHI SANKYO HEALTHCARE CO., LTD.
|
New Position
|
Name
|
Current Position
|
|
Member of the Board, Executive Officer,
in charge of Corporate Planning & Corporate Administration
|
Katsuhiko Yoshida
|
Member of the Board, Executive Officer,
Vice president of Corporate Planning Department
|
|
Member of the Board, Corporate Officer, Vice President of Sales Administration Department
|
Yasuhiro Kawanaka
|
Member of the Board, Corporate Officer, Head of Sales Division
|
3．KITASATO DAIICHI SANKYO VACCINE CO., LTD.
|
New Position
|
Name
|
Current Position
|
|
President
（Concurrently serve as: Member of the Board, Senior Executive Officer, Head of Vaccine Business Intelligence Division, Daiichi Sankyo Co.,Ltd）
|
Takeshi Ogita
|
Member of the Audit and Supervisory Board（Outside）
|
|
Executive Vice President
|
Haruhisa Kubota
|
Executive Vice President
and Head of Development Research Division
|
◇Takeshi Ogita will concurrently serve as Member of the Board, Senior Executive Officer, Head of Vaccine Business Intelligence Division, Daiichi Sankyo Co.,Ltd after April 1st, 2014.
◇Masahiro Okabe (current President） will retire on March 31st, 2014.